Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
fda
life sciences
national blog main
2
×
san francisco blog main
accent therapeutics
aducanumab
akouos
alzheimer's disease
amblyotech
asklepios biopharmaceutical
astellas pharmaceuticals
bioeurope
biogen
biomarin pharmaceutical
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
california institute for biomedical research
cancer
cara therapeutics
clinical trials
deals
decibel therapeutics
deerfield management
detroit blog main
detroit top stories
drug development
drug discovery
esperion
europe blog main
europe top stories
financing
frequency therapeutics
gilead sciences
harvard university
What
developing
fda
2
×
ipo
2
×
medicines
activity
affects
americans
approvals
approved
bio
biogen
clamped
covid
date
delays
drug
economic
fast
frequency
hearing
including
isn’t
loss
lot
meds
millions
new
oric’s
plans
regenerative
roundup
showing
spread
testing
therapeutics
treat
work
Language
unset
Current search:
ipo
×
fda
×
" national blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds